Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J's Rybrevant Receives EU Approval for Expanded Use in NSCLC
02:05pm, Wednesday, 28'th Aug 2024
The European Commission approves JNJ's Rybrevant in combination with chemotherapy for treating EGFR-mutated NSCLC following failure of prior therapy.
Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts
06:45pm, Tuesday, 27'th Aug 2024
Johnson & Johnson (JNJ) closed the most recent trading day at $162.95, moving -1.01% from the previous trading session.
If I Could Only Buy 2 High Dividend Yield Companies In August 2024
02:00pm, Tuesday, 27'th Aug 2024
In this article, I will present you with two high dividend yield companies that, I believe, are presently attractive, given their current Valuation, financial robustness, and leading competitive posit
JNJ Stock A Winner Right Now?
08:00am, Tuesday, 27'th Aug 2024
We believe that Johnson & Johnson stock (NYSE: JNJ) is currently a better pick than Procter & Gamble stock (NYSE: PG) as it appears to show more promise over the coming years. The decision to invest o
Four RYBREVANT® (amivantamab-vmjw) studies feature compelling new findings in lung and colorectal cancers New TAR-200 data reveal the potential of organ-sparing therapy for the treatment of bladder c
340B: AHF Blasts J&J's Illegal Rebate Plan, Urges Senate to Act
04:57pm, Monday, 26'th Aug 2024
WASHINGTON--(BUSINESS WIRE)--340B: AHF Blasts J&J's Illegal Rebate Plan, Urges Senate to Act.
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
10:31am, Monday, 26'th Aug 2024
The approval of J&J's (JNJ) Balversa (erdafitinib) for treating unresectable or metastatic urothelial carcinoma is based on data from the phase III THOR study.
10 Undervalued Dividend Growth Stocks: August 2024
09:00am, Monday, 26'th Aug 2024
I rank a selection of undervalued dividend growth stocks in the Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by qua
2 Unstoppable Stocks That Are Screaming Buys in August
06:49am, Monday, 26'th Aug 2024
Strong companies with profitable businesses and a path to future growth can drive investor returns over the long run. Johnson & Johnson is still working to resolve talc claims, but its business is doi
Is Johnson & Johnson Stock a Buy?
06:17am, Sunday, 25'th Aug 2024
Johnson & Johnson faces challenges related to a new law in the U.S. The company can find ways to navigate this problem. The stock remains a great pick for income seekers.
3 of the Best Long-Term Stocks to Buy Now and Hold Forever
07:43am, Saturday, 24'th Aug 2024
Investors have long sought to maximize gains by timing the market – buying low and selling high.
J&J in talks with holdouts to $6.5 billion talc settlement
02:04pm, Friday, 23'rd Aug 2024
Johnson & Johnson said on Friday it is negotiating with plaintiffs' lawyers who have opposed the company's proposed settlement of lawsuits alleging its baby powder and other talc products caused cance
Johnson & Johnson: The Dividend King Is Back
11:19am, Friday, 23'rd Aug 2024
Johnson & Johnson is regaining momentum with strong growth in its Innovative Medicine and MedTech segments, driven by new products and strategic acquisitions. The company's robust financials, includin
Johnson & Johnson: Don't Bet Against Double Compounding
12:40pm, Thursday, 22'nd Aug 2024
JNJ bulls often praise its dividends - rightfully. However, the above-average yield and remarkable dividend record understate the attractiveness. Investors should focus on total shareholder returns, w
How To Allocate $100,000 In A Dividend Portfolio: A Strategic Guide For Income And Growth
09:00am, Thursday, 22'nd Aug 2024
I will demonstrate how you could allocate the amount of $100,000 by following the current composition of The Dividend Income Accelerator Portfolio, effectively balancing dividend income and dividend g
